66577-59-1

Usage

Uses

Used in Personal Care Industry:
Heptadecane-1,17-diol is utilized as an emollient and hydrating agent in the formulation of personal care products such as moisturizers, lip balms, and lotions. Its ability to soften and smooth the skin, as well as to lock in moisture, contributes to its widespread use in this industry.
Used in Industrial Applications:
In industrial settings, heptadecane-1,17-diol serves as a lubricant, leveraging its properties to reduce friction between surfaces and enhance the performance of machinery.
Used in Surfactant Production:
Heptadecane-1,17-diol is employed as a surfactant in the creation of emulsions and foam stabilizers, where it helps to maintain the stability of mixtures and improve the performance of cleaning and personal care products.
Used in Pharmaceutical Industry:
Heptadecane-1,17-diol has been investigated for its potential applications in pharmaceuticals, suggesting that it may have uses in the development of new drugs or drug delivery systems.
Used as a Precursor in Organic Synthesis:
Furthermore, heptadecane-1,17-diol is recognized as a precursor in the synthesis of other organic compounds, indicating its importance in the realm of organic chemistry and the potential for further applications in various chemical industries.

Upstream product

• 21964-52-3 α,ω-heptadecadiene 
• 4549-33-1 1,9-Dibromononane 
• 19102-92-2 dimethyl heptadecane-1,17-dioate 
• 21964-50-1 pentadeca-1,14-diene 
• 81726-81-0 1,15-dibromopentadecane 
• 14722-40-8 1,15-pentadecanediol 
• 106-02-5 pentadecanolide 
• 42234-86-6 diethyl heptadecanedioate 
• 71-36-3 butan-1-ol 

Downstream Products

• 338389-27-8 17-bromoheptadecan-1-ol 
• 885514-62-5 17-acetoxyheptadecan-1-al 
• 885514-61-4 17-acetoxyheptadecan-1-ol 
• 81726-82-1 1,17-dibromo-heptadecane 

Relevant academic research and scientific papers

Synthesis of 13C-labelled ω-hydroxy carboxylic acids of the general formula HO213C-(CH2)n-CH2OH or HO2C-(CH2)n-13CH2OH (n = 12, 16, 20, 28)

13C-labelled ω-hydroxy-carboxylic acids HO213C-(CH2)n-CH2OH or HO2C-(CH2)n-13CH2OH (n = 12, 16, 20, 28) with 13C labels selectively introduced either at the carboxy group or at the primary alcohol function at the end of the hydrocarbon chain have been synthesized. Different synthetic strategies had to be applied depending on the position of the label, the chain length of the respective synthetic target and due to economic considerations. 13C labels in general were introduced by nucleophilic substitution of a suitable leaving group with labelled potassium cyanide and subsequent hydrolysis of the nitriles to produce the corresponding labelled carboxy functions, which may also be reduced to give the labelled primary alcohol group. All new compounds are characterized by GC/MS, IR and NMR methods as well as by elemental analysis.

Synthetic polyester from algae oil

Current efforts to technically use microalgae focus on the generation of fuels with a molecular structure identical to crude oil based products. Here we suggest a different approach for the utilization of algae by translating the unique molecular structures of algae oil fatty acids into higher value chemical intermediates and materials. A crude extract from a microalga, the diatom Phaeodactylum tricornutum, was obtained as a multicomponent mixture containing amongst others unsaturated fatty acid (16:1, 18:1, and 20:5) phosphocholine triglycerides. Exposure of this crude algae oil to CO and methanol with the known catalyst precursor [{1,2-(tBu2PCH2) 2C6H4}Pd(OTf)](OTf) resulted in isomerization/methoxycarbonylation of the unsaturated fatty acids into a mixture of linear 1,17- and 1,19-diesters in high purity (>99%). Polycondensation with a mixture of the corresponding diols yielded a novel mixed polyester-17/19.17/19 with an advantageously high melting and crystallization temperature. Algae as feedstock: Crude algae oil from the strain Phaeodactylum tricornutum was transformed into polycondensation-grade purity monomers and thus utilized as feedstock for the production of an algae oil based polyester.

Pyridinecarboxamide derivatives

Pyridinecarboxamide derivatives of the formula STR1 (wherein n represents an integer of 14-18, and R represents a hydrogen atom or a straight or branched C1 -C4 alkyl group) or physiologically acceptable salts thereof. The compounds have excellent inhibiting activity of cerebral edema, especially ischemic cerebral edema, and inhibiting activity of delayed death of neuronal cells (an inhibiting activity of Ca-influx in neuronal cells). Cerebral edema is a pathologic condition accompanying cerebrovascular disorders, especially the acute stage of cerebrovascular disorders and then the compounds are useful as an agent for inhibiting cerebral edema or a therapeutic agent for cerebrovascular disorders. Moreover, the compounds have no hypotensive action which is considered to be side-effect in treating the acute stage cerebrovascular disorders and hardly show a behavior suppressing action so that they are an excellent therapeutic agent for, in particular, the acute stage cerebrovascular disorders. Moreover, the compounds show a cerebral protective activity (an anti-anoxic activity), an increasing activity of cerebral blood flow, and an inhibiting activity of lipid peroxidation and these activities may lead to the increased utility as a therapeutic agent for cerebrovascular disorders.